Squarepoint Ops LLC Gilead Sciences, Inc. Call Options Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$66.59 - $83.99 $2.04 Million - $2.57 Million
30,600 Added 37.68%
111,800 $9.37 Million
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $3.04 Million - $3.51 Million
48,100 Added 145.32%
81,200 $5.57 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $21,474 - $26,187
-300 Reduced 0.9%
33,100 $2.42 Million
Q4 2023

Feb 14, 2024
BUY
$73.27 - $83.09 $571,506 - $648,102
7,800 Added 30.47%
33,400 $2.71 Million
Q2 2023

Aug 14, 2023
SELL
$76.01 - $86.7 $1.55 Million - $1.77 Million
-20,400 Reduced 44.35%
25,600 $1.97 Million
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $3.56 Million - $4.05 Million
46,000 New
46,000 $3.82 Million
Q1 2022

May 16, 2022
SELL
$57.92 - $72.58 $3.56 Million - $4.46 Million
-61,500 Reduced 45.69%
73,100 $4.35 Million
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $862,903 - $979,412
13,300 Added 10.96%
134,600 $9.77 Million
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $500,906 - $540,422
-7,400 Reduced 5.75%
121,300 $8.47 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $6.17 Million - $6.74 Million
-97,200 Reduced 43.03%
128,700 $8.86 Million
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $13.6 Million - $15.5 Million
225,900 New
225,900 $14.6 Million

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email